CSIMarket
 

Arena Pharmaceuticals Inc   (NASDAQ: ARNA)

Arena Pharmaceuticals Inc 's

Competitiveness




 

ARNA Sales vs. its Competitors Q4 2021



Comparing the current results to its competitors, Arena Pharmaceuticals Inc reported Revenue increase in the 4 quarter 2021 by 45.95 % year on year, while most of its competitors have experienced contraction in revenues by -40.36 %, achieved in the same quarter.

List of ARNA Competitors





Revenue Growth Comparisons




Net Income Comparison


Arena Pharmaceuticals Inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<<  ARNA Stock Performance Comparisons



  

Overall company Market Share Q4 2021

Due to outstanding performance in Overall company, revenue grew by 45.95 % Arena Pharmaceuticals Inc improved its market share, to approximately 0.04 %.




<<  More on ARNA Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Arena Pharmaceuticals Inc




Anebulo Pharmaceuticals Inc
Share Performance



-70.62%
This Year



Anebulo Pharmaceuticals Inc
Profile

Anebulo Pharmaceuticals Inc operates on a business model focused on developing and commercializing innovative therapeutic solutions for respiratory diseases. They aim to identify and target unmet medical needs through research and development of novel drug formulations and delivery systems. By partnering with stakeholders and leveraging their expertise, Anebulo Pharmaceuticals Inc aims to provide effective treatments and improve the lives of patients with respiratory conditions.

More about Anebulo Pharmaceuticals Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 13.640 mill. $ - mill. $ -7.979 mill.


Indivior Pharmaceuticals Inc
Share Performance



-10.22%
This Quarter



Indivior Pharmaceuticals Inc
Profile

The company develops, markets, and sells pharmaceutical products.

More about Indivior Pharmaceuticals Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 4,259.400 mill. $ 1,333.000 mill. $ 356.000 mill.


Ironwood Pharmaceuticals inc
Share Performance



+202.67%
One Year



Ironwood Pharmaceuticals inc
Profile

Ironwood Pharmaceuticals Inc is a biotechnology company that focuses on the development and commercialization of medicines for gastrointestinal disorders. Their business model involves discovering, developing, and marketing innovative treatments for conditions like irritable bowel syndrome and chronic constipation. They aim to achieve growth and profitability by leveraging their research capabilities and collaborating with strategic partners in the healthcare industry.

More about Ironwood Pharmaceuticals inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 662.865 mill. $ 389.316 mill. $ 129.868 mill.


Landos Biopharma Inc
Share Performance



+3.38%
30 Days



Landos Biopharma Inc
Profile

Lando's Biopharma Inc is a pharmaceutical company that focuses on developing and commercializing innovative biopharmaceutical products to address unmet medical needs. Their business model revolves around conducting research and development, obtaining regulatory approvals, and marketing and selling their products in the global pharmaceutical market.

More about Landos Biopharma Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 142.340 mill. $ - mill. $ -24.798 mill.


Marinus Pharmaceuticals Inc
Share Performance



+3.00%
This Year



Marinus Pharmaceuticals Inc
Profile

Marinus Pharmaceuticals Inc operates on a business model centered around developing and commercializing innovative therapeutics for rare neurological disorders.

More about Marinus Pharmaceuticals Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 31.476 mill. $ 31.466 mill. $ -140.491 mill.

21 more competitors available

Sign in to see all competitors

Sources: Arena Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Arena Pharmaceuticals Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.